Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros










Base de dados
Intervalo de ano de publicação
1.
Metabolomics ; 14(4): 51, 2018 03 16.
Artigo em Inglês | MEDLINE | ID: mdl-30830356

RESUMO

INTRODUCTION: During in vitro fertilization (IVF), the hyper response to controlled ovarian stimulation (COS) is a common characteristic among patients diagnosed with polycystic ovary syndrome (PCOS), although non-diagnosed patients may also demonstrate this response. OBJECTIVES: In an effort to investigate follicular metabolic characteristics associated with hyper response to COS, the present study analyzed follicular fluid (FF) samples from patients undergoing IVF. METHODS: FF samples were obtained from patients with PCOS and hyper response during IVF (PCOS group, N = 15), patients without PCOS but with hyper response during IVF (HR group, N = 44), and normo-responder patients receiving IVF (control group, N = 22). FF samples underwent Bligh and Dyer extraction, followed by metabolomic analysis by ultra-performance liquid chromatography mass spectrometry, considering two technical replicates. Clinical data was analyzed by ANOVA and chi-square tests. The metabolomic dataset was analyzed by multivariate statistics, and the significance of biomarkers was confirmed by ANOVA. RESULTS: Clinical data showed differences regarding follicles production, oocyte and embryo quality. From the 15 proposed biomarkers, 14 were of increased abundance in the control group and attributed as fatty acids, diacylglycerol, triacylglycerol, ceramide, ceramide-phosphate, phosphatidylcholine, and sphingomyelin. The PCOS patients showed increased abundance of a metabolite of m/z 144.0023 that was not attributed to a class. CONCLUSION: The clinical and metabolic similarities observed in the FF of hyper responders with and without PCOS diagnosis indicate common biomarkers that could assist on the development of accessory tools for assessment of IVF parameters.


Assuntos
Fertilização in vitro , Líquido Folicular/metabolismo , Metabolômica , Oócitos/metabolismo , Indução da Ovulação , Síndrome do Ovário Policístico/metabolismo , Adulto , Cromatografia Líquida de Alta Pressão , Feminino , Humanos , Espectrometria de Massas
2.
J Assist Reprod Genet ; 32(12): 1817-25, 2015 Dec.
Artigo em Inglês | MEDLINE | ID: mdl-26497128

RESUMO

PURPOSE: The aim of the present study was to analyze the lipid profile of follicular fluid from patients with endometriosis and endometrioma who underwent in vitro fertilization treatment (IVF). METHODS: The control group (n = 10) was composed of women with tubal factor or minimal male factor infertility who had positive pregnancy outcomes after IVF. The endometriosis group consisted of women with endometriosis diagnosed by videolaparoscopy (n = 10), and from the same patients, the endometriomas fluids were collected, which composed the endometrioma group (n = 10). From the follicular fluid and endometriomas, lipids were extracted by the Bligh and Dyer method, and the samples were analyzed by tandem mass spectrometry. RESULTS: We observed phosphatidylglycerol phosphate, phosphatidylcholine, phosphatidylserine, and phosphatidylnositol bisphosphate in the control group. In the endometriosis group, sphingolipids and phosphatidylcholines were more abundant, while in the endometrioma group, sphingolipids and phosphatidylcholines with different m/z from the endometriosis group were found in high abundance. CONCLUSION: This analysis demonstrated that there is a differential representation of these lipids according to their respective groups. In addition, the lipids found are involved in important mechanisms related to endometriosis progress in the ovary. Thus, the metabolomic approach for the study of lipids may be helpful in potential biomarker discovery.


Assuntos
Biomarcadores/metabolismo , Endometriose/diagnóstico , Líquido Folicular/metabolismo , Metabolismo dos Lipídeos , Lipídeos/química , Endometriose/metabolismo , Feminino , Humanos , Metabolômica , Espectrometria de Massas por Ionização por Electrospray
3.
Cell Reprogram ; 13(5): 419-29, 2011 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-21740268

RESUMO

Somatic cell nuclear transfer (SCNT) has had an enormous impact on our understanding of biology and remains a unique tool for multiplying valuable laboratory and domestic animals. However, the complexity of the procedure and its poor efficiency are factors that limit a wider application of SCNT. In this context, oocyte meiotic arrest is an important option to make SCNT more flexible and increase the number of cloned embryos produced. Herein, we show that the use of butyrolactone I in association with brain-derived neurotrophic factor (BDNF) to arrest the meiotic division for 24 h prior to in vitro maturation provides bovine (Bos indicus) oocytes capable of supporting development of blastocysts and full-term cloned calves at least as efficiently as nonarrested oocytes. Furthermore, the procedure resulted in cloned blastocysts with an 1.5- and twofold increase of POU5F1 and IFNT2 expression, respectively, which are well-known markers of embryonic viability. Mitochondrial DNA (mtDNA) copy number was diminished by prematuration in immature oocytes (718,585±34,775 vs. 595,579±31,922, respectively, control and treated groups) but was unchanged in mature oocytes (522,179±45,617 vs. 498,771±33,231) and blastocysts (816,627±40,235 vs. 765,332±51,104). To our knowledge, this is the first report of cloned offspring born to prematured oocytes, indicating that meiotic arrest could have significant implications for laboratories working with SCNT and in vitro embryo production.


Assuntos
4-Butirolactona/análogos & derivados , Fator Neurotrófico Derivado do Encéfalo/farmacologia , Clonagem de Organismos/métodos , Meiose/efeitos dos fármacos , Técnicas de Transferência Nuclear , Oócitos/metabolismo , Inibidores de Proteínas Quinases/farmacologia , 4-Butirolactona/farmacologia , Animais , Blastocisto/citologia , Blastocisto/metabolismo , Bovinos , Feminino , Regulação da Expressão Gênica no Desenvolvimento/efeitos dos fármacos , Interferon Tipo I/biossíntese , Fator 3 de Transcrição de Octâmero/biossíntese , Oócitos/citologia , Gravidez , Proteínas da Gravidez/biossíntese
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA
...